Oriza, Boyu Join $150M Series A Round In Bio-Pharma Start-Up CStone
July 4, 2016 — 13:39 CST
This Data Is Locked!
This area is available only to Subscribers.
Oriza Seed Venture Capital, Boyu Capital and WuXi Healthcare Ventures have invested RMB975 million (US$150 million) in CStone Pharmaceuticals Co., Ltd, a bio-pharmaceutical company devoted... [DATA LOCKED]
UNLOCK DATA
Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals